Skip to main content

Table 4 Medium-late complications

From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome

Readmission [n (%)] 15 (65)
Days after discharge [Mean ± SD (range)] 102.4 ± 136.2 (10–515)
Re- surgery [n (%)] 7 (30)
Transfusion [n (%)] 9 (39)
Circulatory event [n (%)]
 Thromboembolism 1 (4)
 Cardiovascular event 0 (0)
Urinary [n (%)]
 No 13 (57)
 Pyelonephritis 6 (26)
 Fistula 2 (9)
 Ureteral stricture 7 (30)
 Bricker failure and reconstruction 1 (4)
 Renal failure 4 (17)
Gastrointestinal [n (%)]
 No 15 (65)
 Paralytic ileus 5 (22)
 Small bowel fistula/perforation 4 (17)
 Eventration 1 (4)
Infectious [n (%)]
 No 13 (57)
 Abscess 4 (17)
 Wound infection 4 (17)
 Sepsis 6 (26)
Others [n (%)]
 Acute limb ischemia 1 (4)
 Coagulopathy 1 (4)
 Septic shock 1 (4)
 Abdominal cloaca (Both ureter and bowel fistula) 1 (4)
Clavien Dindo [Mean ± SD (range)]
Grade II 1.4 ± 1.4 (0–4)
Grade III 1.1 ± 1.5 (0–6)
Grade IV 0.8  ± 0.9 (0–3)
Patients with complications [n (%)]
Grade II 15 (65)
Grade III 11 (48)
Grade IV 3 (13)
Grade V 2 (9)